This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
A new drug for coronavirus approved in Russia
The drug "Coronavir" received a registration certificate. It is intended to treat a new coronavirus.
According to State Register of Medicines, registration completed July 6th. The validity of the certificate and the introduction into civil circulation are established until January 1, 2021. According to information RBC the drug will go into circulation until the end of July 2020.
"Coronavir" contains the active ingredient favipiravir, which is already used to treat coronavirus. The drug was registered by OOO Tekhnologiya medicinskii, and it will be produced by the Yaroslavl company R-Pharm. The medicine will be produced in pill form.
Another coronavirus drug developed in Russia is currently undergoing clinical trials. Avivavir has been registered On May 29, June 3, it was included in the last, seventh edition of the guidelines for the treatment of coronavirus. Residents of Russia get it for free, to the country's hospitals already sent the first batch. In the free sale of the drug will not be yet.